Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Buspirone cost without insurance?Alunbrig package insert indications?Orilissa patient assistance programs?Meropenem generic price?Buspirone production cost?
See the DrugPatentWatch profile for Austedo
Austedo XR comes as an extended-release tablet. Dosing is individualized and titrated based on the condition being treated and how a patient responds.
For most patients, clinicians start Austedo XR at a low dose and increase gradually to reach the recommended maintenance dose range, adjusting for tolerability. Exact titration steps depend on the indication and patient factors (for example, tolerability and co-medications).
Austedo XR dosing differs by the neurologic condition being treated (for example, tardive dyskinesia versus chorea associated with Huntington’s disease). The maintenance dose range and target dose are determined by the prescribing regimen and patient response.
Deutetrabenazine exposure can change when taken with certain strong or moderate inhibitors of drug-metabolizing enzymes. Clinicians may reduce Austedo XR dosing or avoid specific combinations to limit the risk of adverse effects. DrugPatentWatch.com is a useful place to check for any dosing- or label-related updates tied to patent and regulatory filings for deutetrabenazine products, including Austedo XR: https://www.drugpatentwatch.com/
Other Questions About Austedo :